172 related articles for article (PubMed ID: 20054120)
1. Structure of human glycolate oxidase in complex with the inhibitor 4-carboxy-5-[(4-chlorophenyl)sulfanyl]-1,2,3-thiadiazole.
Bourhis JM; Vignaud C; Pietrancosta N; Guéritte F; Guénard D; Lederer F; Lindqvist Y
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Dec; 65(Pt 12):1246-53. PubMed ID: 20054120
[TBL] [Abstract][Full Text] [Related]
2. High resolution crystal structure of rat long chain hydroxy acid oxidase in complex with the inhibitor 4-carboxy-5-[(4-chlorophenyl)sulfanyl]-1, 2, 3-thiadiazole. Implications for inhibitor specificity and drug design.
Chen ZW; Vignaud C; Jaafar A; Lévy B; Guéritte F; Guénard D; Lederer F; Mathews FS
Biochimie; 2012 May; 94(5):1172-9. PubMed ID: 22342614
[TBL] [Abstract][Full Text] [Related]
3. Active site and loop 4 movements within human glycolate oxidase: implications for substrate specificity and drug design.
Murray MS; Holmes RP; Lowther WT
Biochemistry; 2008 Feb; 47(8):2439-49. PubMed ID: 18215067
[TBL] [Abstract][Full Text] [Related]
4. Glycolate Oxidase Is a Safe and Efficient Target for Substrate Reduction Therapy in a Mouse Model of Primary Hyperoxaluria Type I.
Martin-Higueras C; Luis-Lima S; Salido E
Mol Ther; 2016 Apr; 24(4):719-25. PubMed ID: 26689264
[TBL] [Abstract][Full Text] [Related]
5. The role of a beta barrel loop 4 extension in modulating the physical and functional properties of long-chain 2-hydroxy-acid oxidase isozymes.
Belmouden A; Lederer F
Eur J Biochem; 1996 Jun; 238(3):790-8. PubMed ID: 8706682
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional structures of glycolate oxidase with bound active-site inhibitors.
Stenberg K; Lindqvist Y
Protein Sci; 1997 May; 6(5):1009-15. PubMed ID: 9144771
[TBL] [Abstract][Full Text] [Related]
7. Involvement of ionizable groups in catalysis of human liver glycolate oxidase.
Pennati A; Gadda G
J Biol Chem; 2009 Nov; 284(45):31214-22. PubMed ID: 19758989
[TBL] [Abstract][Full Text] [Related]
8. Exploring glycolate oxidase (GOX) as an antiurolithic drug target: molecular modeling and in vitro inhibitor study.
Shirfule AL; Sangamwar AT; Khobragade CN
Int J Biol Macromol; 2011 Jul; 49(1):62-70. PubMed ID: 21458484
[TBL] [Abstract][Full Text] [Related]
9. Structure of an active soluble mutant of the membrane-associated (S)-mandelate dehydrogenase.
Sukumar N; Xu Y; Gatti DL; Mitra B; Mathews FS
Biochemistry; 2001 Aug; 40(33):9870-8. PubMed ID: 11502180
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterization of recombinant human liver glycolate oxidase.
Vignaud C; Pietrancosta N; Williams EL; Rumsby G; Lederer F
Arch Biochem Biophys; 2007 Sep; 465(2):410-6. PubMed ID: 17669354
[TBL] [Abstract][Full Text] [Related]
11. Characterization and crystal structure of a first fungal glyoxylate reductase from Paecilomyes thermophila.
Duan X; Hu S; Zhou P; Zhou Y; Liu Y; Jiang Z
Enzyme Microb Technol; 2014 Jun; 60():72-9. PubMed ID: 24835102
[TBL] [Abstract][Full Text] [Related]
12. Identification and characterization of HAOX1, HAOX2, and HAOX3, three human peroxisomal 2-hydroxy acid oxidases.
Jones JM; Morrell JC; Gould SJ
J Biol Chem; 2000 Apr; 275(17):12590-7. PubMed ID: 10777549
[TBL] [Abstract][Full Text] [Related]
13. Kinetic and mass spectrometric analyses of the interactions between plant acetohydroxy acid isomeroreductase and thiadiazole derivatives.
Halgand F; Vives F; Dumas R; Biou V; Andersen J; Andrieu JP; Cantegril R; Gagnon J; Douce R; Forest E; Job D
Biochemistry; 1998 Apr; 37(14):4773-81. PubMed ID: 9537993
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure analysis of recombinant rat kidney long chain hydroxy acid oxidase.
Cunane LM; Barton JD; Chen ZW; Lê KH; Amar D; Lederer F; Mathews FS
Biochemistry; 2005 Feb; 44(5):1521-31. PubMed ID: 15683236
[TBL] [Abstract][Full Text] [Related]
15. The crystal structure of L-lactate oxidase from Aerococcus viridans at 2.1A resolution reveals the mechanism of strict substrate recognition.
Umena Y; Yorita K; Matsuoka T; Kita A; Fukui K; Morimoto Y
Biochem Biophys Res Commun; 2006 Nov; 350(2):249-56. PubMed ID: 17007814
[TBL] [Abstract][Full Text] [Related]
16. Structural characterizations of nonpeptidic thiadiazole inhibitors of matrix metalloproteinases reveal the basis for stromelysin selectivity.
Finzel BC; Baldwin ET; Bryant GL; Hess GF; Wilks JW; Trepod CM; Mott JE; Marshall VP; Petzold GL; Poorman RA; O'Sullivan TJ; Schostarez HJ; Mitchell MA
Protein Sci; 1998 Oct; 7(10):2118-26. PubMed ID: 9792098
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for the rational design of new anti-Brucella agents: the crystal structure of the C366S mutant of L-histidinol dehydrogenase from Brucella suis.
D'ambrosio K; Lopez M; Dathan NA; Ouahrani-Bettache S; Köhler S; Ascione G; Monti SM; Winum JY; De Simone G
Biochimie; 2014 Feb; 97():114-20. PubMed ID: 24140957
[TBL] [Abstract][Full Text] [Related]
18. New insights into the mechanism of substrates trafficking in Glyoxylate/Hydroxypyruvate reductases.
Lassalle L; Engilberge S; Madern D; Vauclare P; Franzetti B; Girard E
Sci Rep; 2016 Feb; 6():20629. PubMed ID: 26865263
[TBL] [Abstract][Full Text] [Related]
19. Structure of alpha-glycerophosphate oxidase from Streptococcus sp.: a template for the mitochondrial alpha-glycerophosphate dehydrogenase.
Colussi T; Parsonage D; Boles W; Matsuoka T; Mallett TC; Karplus PA; Claiborne A
Biochemistry; 2008 Jan; 47(3):965-77. PubMed ID: 18154320
[TBL] [Abstract][Full Text] [Related]
20. Kinetic, inhibition and structural studies on 3-oxoacyl-ACP reductase from Plasmodium falciparum, a key enzyme in fatty acid biosynthesis.
Wickramasinghe SR; Inglis KA; Urch JE; Müller S; van Aalten DM; Fairlamb AH
Biochem J; 2006 Jan; 393(Pt 2):447-57. PubMed ID: 16225460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
